Unveiling the importance of polymorphism in drug development: Insights from Ardena
Ardena shares the latest insights on the critical role of polymorphism in drug development. Giovanna Brancatelli, Principal Scientist and Scientific Director at Ardena Solid State Research, has authored a comprehensive article featured in the International Pharmaceutical Industry Journal Summer 2024 issue. The article delves into how polymorph screening can significantly impact the stability, efficacy, and quality of drug products.
Learn why early-stage polymorph screens are essential, how they mitigate risks, and the innovative methods Ardena employs to ensure robust drug development.
Read the full article here.
Find more news here.